7 research outputs found
Unfitness to Plead. Volume 1: Report.
This has been produced along with Volume 2: Draft Legislation as a combined document
Presented to Parliament pursuant to section 3(2) of the Law Commissions Act 1965
Ordered by the House of Commons to be printed on 12 January 201
The BraveNet prospective observational study on integrative medicine treatment approaches for pain
BACKGROUND: Chronic pain affects nearly 116 million American adults at an estimated cost of up to $635 billion annually and is the No. 1 condition for which patients seek care at integrative medicine clinics. In our Study on Integrative Medicine Treatment Approaches for Pain (SIMTAP), we observed the impact of an integrative approach on chronic pain and a number of other related patient-reported outcome measures. METHODS: Our prospective, non-randomized, open-label observational evaluation was conducted over six months, at nine clinical sites. Participants received a non-standardized, personalized, multimodal approach to chronic pain. Validated instruments for pain (severity and interference levels), quality of life, mood, stress, sleep, fatigue, sense of control, overall well-being, and work productivity were completed at baseline and at six, 12, and 24Â weeks. Blood was collected at baseline and week 12 for analysis of high-sensitivity C-reactive protein and 25-hydroxyvitamin D levels. Repeated-measures analysis was performed on data to assess change from baseline at 24Â weeks. RESULTS: Of 409 participants initially enrolled, 252 completed all follow-up visits during the 6Â month evaluation. Participants were predominantly white (81%) and female (73%), with a mean age of 49.1Â years (15.44) and an average of 8.0 (9.26) years of chronic pain. At baseline, 52% of patients reported symptoms consistent with depression. At 24Â weeks, significantly decreased pain severity (â23%) and interference (â28%) were seen. Significant improvements in mood, stress, quality of life, fatigue, sleep and well-being were also observed. Mean 25-hydroxyvitamin D levels increased from 33.4 (17.05) ng/mL at baseline to 39.6 (16.68) ng/mL at week 12. CONCLUSIONS: Among participants completing an integrative medicine program for chronic pain, significant improvements were seen in pain as well as other relevant patient-reported outcome measures. TRIAL REGISTRATION: ClinicalTrials.gov, NCT0118634
The Advocate's Gateway
In 2012, following a 2011 report by The Advocacy Training Council, The Advocate's Gateway project was founded in order to change criminal justice practitioners' approaches to vulnerable witnesses.
The Advocateâs Gateway is designed to give advocates easy internet access to practical guidance for working with witnesses and defendants with communication needs, and to give trainers resources to use when teaching advocates about the handling of vulnerable witnesses and dependents